Back in 2007, Shoukhrat Mitalipov, Ph.D., a researcher at OHSU’s Oregon National Primate Research Center, received international attention for developing a novel method for cloning stem cells. Dr. Mitalipov’s method involved transplanting DNA from an individual’s skin cells into an egg that could develop into various other cell types—no embryonic stem cells needed. More recently, the U.S. Department of Commerce has issued a patent for Dr. Mitalipov’s stem cell cloning method.
Why is the patent such exciting news for OHSU? In addition to offering safer and more effective treatment options for cardiac and neurological diseases, this patent has the potential to bring revenue to the university and the entire state of Oregon.